ArticleMolecular psychiatry2025

Reply to "Letter to the Editor regarding 'Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone'".

Marjorie R Levinstein et al.PubMed ↗Publisher ↗

No numbers read from the abstract.